Given the potential of additional tax cuts on consumer goods, the consumer staples sector seems a promising bet. We have highlighted five stocks from the in-focus industries in the sector that poses strong...
B&G Foods' (BGS) board of directors announces a 2.2% hike in the company's quarterly dividend rate to 47.5 cents per share, which leads to an annualized dividend yield of 7.2%.
Pinnacle Foods (PF) witnesses sturdy market share growth on a rich product line up. However, higher input costs are a concern.
Church & Dwight's (CHD) stable portfolio of value and premium products, launch of innovative products and aggressive productivity programs are expected to keep driving its performance.
While SUPERVALU's (SVU) wholesale operations yield favorably, retail unit continues to reel under stiff competition.
Campbell (CPB) reports impressive bottom line in third-quarter fiscal 2018. However, management trims its earnings forecast for the fiscal year.
Celsius Holdings (CELH) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
TreeHouse Foods(THS) has been riding on focus on buyouts and its TreeHouse 2020 Plan. However, rising costs pose hurdles.
Conagra Brands (CAG) poised to grow on the back of brand modernizing moves, stronger innovation, buyouts, strategic divestments and lower tax rates.
Zacks.com highlights: Medifast, Myriad Genetics, ICU Medical, Ellie Mae and UGI
Is MEDIFAST (MED) Outperforming Other Consumer Staples Stocks This Year?
We develop a strategy that clearly shows that less risky stocks have the potential to reward shareholders with impressive returns only when certain parameters are considered.
Estee Lauder (EL) has been focused on enhancing its travel retail business, undertaking buyouts and augmenting online sales. However, soft traffic is a concern.
Companhia Brasileira (CBD) has been gaining from continued strength at Assai among other factors. However, the company continues to battle food deflation.
SmarTrend identified an Uptrend for Medifast Inc (NYSE:MED) on March 7th, 2018 at $85.98. In approximately 2 months, Medifast Inc has returned 34.91% as of today's recent price of $115.99.
Hain Celestial (HAIN) third-quarter fiscal 2018 earnings and sales lag estimates but improve year over year.
Sysco (SYY) marks its fourth straight earnings beat in Q3. However, top line lags the Zacks Consensus Estimate for the first time in a while.
Zacks.com featured highlights include: Medifast, Landstar, Avnet, PetMed, Robert Half and Comfort Systems
Despite being hurt by freight and commodity costs, and divestiture of SIF business, TreeHouse Foods' (THS) Q1 results surpass estimates. Also, management retains view.